Announcement

Collapse
No announcement yet.

ibudilast update for progressive ms

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    ibudilast update for progressive ms

    Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study was supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and published in the New England Journal of Medicine.


    https://www.eurekalert.org/pub_relea...-sfm082418.php

    #2
    Quoting from the study, it appears ibudilast reduced the rate of shrinkage in progressive MS by about half... "The rate of change in the brain parenchymal fraction was -0.0010 per year with ibudilast and -0.0019 per year with placebo."

    https://www.ncbi.nlm.nih.gov/pubmed/30157388

    Comment


      #3
      Is FDA approval date known for ibudilast

      Hello, Friends:

      Has anyone encountered information about the anticipated FDA approval date for ibudilast?

      Thank you all for being such a gracious source of support and information.
      Ritalinda

      Comment


        #4
        Originally posted by Defya View Post
        Hello, Friends:

        Has anyone encountered information about the anticipated FDA approval date for ibudilast?

        Thank you all for being such a gracious source of support and information.
        I'm sorry to say, it will still be a number of years as they still need to conduct Phase 3 testing.

        Comment

        Working...
        X